Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.21.2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional paid in capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Balance (in shares) at Dec. 31, 2019   111,798,000      
Balance at Dec. 31, 2019 $ 298,600 $ 746,487 $ 25,394 $ (805) $ (472,476)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   906,000      
Shares issued on exercise of stock options 3,875 $ 5,868 (1,993)    
Exercise of warrants (in shares)   1,000      
Exercise of warrants 1 $ 2 (1)    
Share-based compensation 7,698   7,698    
Net loss (52,476)       (52,476)
Balance (in shares) at Jun. 30, 2020   112,705,000      
Balance at Jun. 30, 2020 257,698 $ 752,357 31,098 (805) (524,952)
Balance (in shares) at Mar. 31, 2020   112,487,000      
Balance at Mar. 31, 2020 279,086 $ 750,940 27,359 (805) (498,408)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   218,000      
Shares issued on exercise of stock options 955 $ 1,418 (463)    
Exercise of warrants (1) $ (1)      
Share-based compensation 4,202   4,202    
Net loss (26,544)        
Balance (in shares) at Jun. 30, 2020   112,705,000      
Balance at Jun. 30, 2020 $ 257,698 $ 752,357 31,098 (805) (524,952)
Balance (in shares) at Dec. 31, 2020 126,725,000 126,725,000      
Balance at Dec. 31, 2020 $ 407,750 $ 944,328 39,383 (805) (575,156)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   1,152,000      
Shares issued on exercise of stock options 6,278 $ 9,518 (3,240)    
Exercise of warrants (in shares)   519,000      
Exercise of warrants 31 $ 726 (695)    
Share-based compensation 15,574   15,574    
Other comprehensive income 13     13  
Net loss $ (97,389)       (97,389)
Balance (in shares) at Jun. 30, 2021 128,396,000 128,396,000      
Balance at Jun. 30, 2021 $ 332,257 $ 954,572 51,022 (792) (672,545)
Balance (in shares) at Mar. 31, 2021   128,121,000      
Balance at Mar. 31, 2021 370,228 $ 952,673 43,889 (799) (625,535)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   275,000      
Shares issued on exercise of stock options 1,279 $ 1,899 (620)    
Exercise of warrants 0        
Share-based compensation 7,753   7,753    
Other comprehensive income 7     7  
Net loss $ (47,010)        
Balance (in shares) at Jun. 30, 2021 128,396,000 128,396,000      
Balance at Jun. 30, 2021 $ 332,257 $ 954,572 $ 51,022 $ (792) $ (672,545)